17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Solithromycin, the fourth generation of ketolides, has been demonstrated potent antibacterial effect against commonly-isolated gram-positive strains. However, Staphylococcus aureus ( S. aureus) strains with a higher solithromycin MIC have already been emerged, the mechanism of which is unknown.

          Methods

          Antimicrobial susceptibility test was performed on 266 strains of S. aureus. The antibiotic resistance phenotype of erm-positive strain was determined by D-zone test. Spontaneous mutation frequency analysis was performed to compare the risk levels for solithromycin resistance among different strains. Efflux pumps and mutational analysis of ribosomal fragments as well as erm(B) gene domains were detected. Quantitative reverse transcription polymerase chain reaction was conducted to compare the transcriptional expression of the erm gene between the constitutive macrolide-lincosamide-streptogramin B (cMLSB)- and inducible MLSB (iMLSB)-phenotypes.

          Results

          In the erm-positive S. aureus strains, the minimum inhibitory concentration (MIC) 50/90 of solithromycin (2/> 16 mg/L) was significantly higher than that in the erm-negative strains (0.125/0.25 mg/L). Of note, the MIC 50 value of the strains with iMLSB (0.25 mg/L) was significantly lower than that of the strains with cMLSB (4 mg/L). A comparison among strains demonstrated that the median mutational frequency in isolates with cMLSB (> 1.2 × 10 − 4) was approximately > 57-fold and > 3333-fold higher than that in iMLSB strains (2.1 × 10 − 6) and in erythromycin-sensitive strains (3.6 × 10 − 8), respectively. The differential antibiotic in vitro activity against strains between cMLSB and iMLSB could not be explained by efflux pump carriers or genetic mutations in the test genes. The expression of the erm genes in strains with cMLSB did not differ from that in strains with iMLSB.

          Conclusions

          The reduced susceptibility to solithromycin by S. aureus was associated with the cMLSB resistance phenotype mediated by erm.

          Electronic supplementary material

          The online version of this article (10.1186/s12879-019-3779-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          Erythromycin resistance by ribosome modification.

          B Weisblum (1995)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Detection of erythromycin-resistant determinants by PCR.

            Erythromycin resistance determinants include Erm methylases, efflux pumps, and inactivating enzymes. To distinguish the different mechanisms of resistance in clinical isolates, PCR primers were designed so that amplification of the partial gene products could be detected in multiplex PCRs. This methodology enables the direct sequencing of amplified PCR products that can be used to compare resistance determinants in clinical strains. Further, this methodology could be useful in surveillance studies of erythromycin-resistant determinants.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.

              Diseases caused by antibiotic-resistant bacteria in hospitals are the outcome of complex relationships between several dynamic factors, including bacterial pathogenicity, the fitness costs of resistance in the human host, and selective forces resulting from interventions such as antibiotic therapy. The emergence and fate of mutations that drive antibiotic resistance are governed by these interactions. In this review, we will examine how different forms of antibiotic resistance modulate bacterial fitness and virulence potential, thus influencing the ability of pathogens to evolve in the context of nosocomial infections. We will focus on 3 important multidrug-resistant pathogens that are notoriously problematic in hospitals: Pseudomonas aeruginosa, Acinetobacter baumannii, and Staphylococcus aureus. An understanding of how antibiotic resistance mutations shape the pathobiology of multidrug-resistant infections has the potential to drive novel strategies that can control the development and spread of drug resistance.
                Bookmark

                Author and article information

                Contributors
                yao719082506@126.com
                1355125180@qq.com
                liduoyun94@163.com
                568646535@qq.com
                doctorwanghongyan@163.com
                473806126@qq.com
                710194599@qq.com
                1006231877@qq.com
                linzw8406@hotmail.com
                +86-0755-26553111 , qiwendeng@hotmail.com
                +86-0755-26553111 , yuzhijiansmu@163.com
                Journal
                BMC Infect Dis
                BMC Infect. Dis
                BMC Infectious Diseases
                BioMed Central (London )
                1471-2334
                19 February 2019
                19 February 2019
                2019
                : 19
                : 175
                Affiliations
                [1 ]ISNI 0000 0001 0472 9649, GRID grid.263488.3, Department of Infectious Diseases and Shenzhen Key Lab for Endogenous Infection, , Shenzhen Nanshan Hospital of Shenzhen University, ; No. 89, Taoyuan Road, Nanshan District, Shenzhen, 518052 China
                [2 ]ISNI 0000 0004 0619 8943, GRID grid.11841.3d, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, , School of Basic Medical Science and Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, ; No.130, Dongan road, Xuhui District, Shanghai, 200032 China
                Author information
                http://orcid.org/0000-0002-5677-2064
                Article
                3779
                10.1186/s12879-019-3779-8
                6381629
                30782125
                c1492bd7-b4dd-42ee-863b-e89f273a8041
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 22 August 2018
                : 4 February 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: No.81170370
                Award ID: No.81601797
                Award Recipient :
                Funded by: Shenzhen Scientific Research Program
                Award ID: No.JCYJ20170412143551332, JCYJ20170307153714512, JCYJ20170307153919735, JCYJ20170307153425389
                Award Recipient :
                Funded by: Shenzhen Health and Family Planning Commission
                Award ID: No.SZFZ2017063, SZXJ2017032, SZFZ2017036, No.201601058
                Award Recipient :
                Funded by: provincial medical funds of Guangdong
                Award ID: No.B2017019, 2014A031313718, A2018163
                Award Recipient :
                Funded by: the Shenzhen Nanshan District Scientific Research Program of the People’s Republic of China
                Award ID: No.2016010, No.2017013, No.2017015, No.2017026, No.2017027
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2019

                Infectious disease & Microbiology
                staphylococcus aureus,constitutive macrolide-lincosamide-streptogramin b (cmlsb) resistance,solithromycin

                Comments

                Comment on this article